Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-12-26FDA Approved: CHOLESTYRAMINE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for cholestyramine from EPIC PHARMA, LLC.
-
FDA approval · 2024-12-19FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for the ezetimibe and simvastatin combination from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2024-12-17FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for atorvastatin calcium (generic) from Ascend Laboratories, LLC, for this ANDA, approving regulator…
-
FDA approval · 2024-12-09FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic rosuvastatin calcium product from Quallent Pharmaceuticals Health LLC under ANDA20…
-
FDA approval · 2024-12-05FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium from Mylan Pharmaceuticals Inc., authorizing the continued marketing of the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-12-04FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., enabling the generic atorvastatin …
-
FDA approval · 2024-12-03FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved an Abbreviated New Drug Application for Colestipol hydrochloride by Ingenus Pharmaceuticals, LLC, establishing a generic versio…
-
FDA approval · 2024-11-27FDA Approved: SIMVASTATIN — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' original application for a generic simvastatin product, adding another generic option for choleste…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Role of Coronary CTA on Lipid Management and Risk Factors Control in an Asymptomatic Chinese Population [NA]
This clinical trial update examines whether coronary CTA can influence lipid management and risk-factor control in asymptomatic Chinese adul…
-
FDA approval · 2024-11-20FDA Approved: REPATHA — Supplemental Application (Amgen USA Inc.)
The FDA approved a supplemental application for Repatha (evolocumab) submitted by Amgen USA Inc.
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome [NA]
An update on a Rutgers-sponsored trial evaluating 'Food is Medicine' versus 'Lifestyle Medicine' approaches for cardiovascular-kidney-metabo…
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial. [NA]
A completed human trial evaluating the lipid-lowering effect of Bergavit in individuals with hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Community-based E-Health Program for Older Adults Living With Chronic Diseases [NA]
A completed clinical trial evaluating a community-based e-health program for older adults living with diabetes mellitus, hypertension, and h…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Effects of Olive Oil and MLCT on Glycolipid Homeostasis in Patients With Metabolic Syndrome [NA]
The clinical trial update reports completion of a study evaluating the effects of olive oil and MLCT on glycolipid homeostasis in patients w…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals [NA]
This completed clinical trial from the National University of Singapore investigated the effect of black rice anthocyanin in mixed meals on …
-
FDA approval · 2024-11-13FDA Approved: FENOFIBRATE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's fenofibrate as an Original Application generic (ANDA 210248). This marks the approval of a g…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
A completed pilot study evaluating whether maternal lipid profiles can predict adverse maternal and neonatal outcomes during pregnancy.
-
FDA approval · 2024-11-06FDA Approved: ROSUVASTATIN — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for rosuvastatin by Macleods Pharmaceuticals Limited, establishing a generic rosuvastatin product. Thi…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population
A completed clinical trial assessing how SLCO1B1 rs2306283 polymorphism affects the efficacy and safety of atorvastatin in individuals with …
-
FDA approval · 2024-11-04FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin by Prasco Laboratories.
-
FDA approval · 2024-11-04FDA Approved: PITAVASTATIN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for pitavastatin calcium under ANDA205955. The approval pertains to the generic pitavastatin product…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Natural Heart Health Supplement Trial [Phase 1]
Phase 1 clinical trial update for a natural heart health supplement from Efforia, Inc, evaluating effects on cholesterol (total and HDL); th…
-
FDA approval · 2024-10-31FDA Approved: CHOLESTYRAMINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the original ANDA for cholestyramine from Macleods Pharmaceuticals Limited, a bile acid sequestrant used to reduce elevated tot…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Technology-Assisted Cholesterol Trial in Consumers (TACTiC) [Phase 3]
Phase 3 trial update for a technology-assisted cholesterol management study (TACTiC) sponsored by AstraZeneca has completed enrollment with …
-
FDA approval · 2024-10-16FDA Approved: ROSUVASTATIN CALCIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for rosuvastatin calcium from Rising Pharma Holdings, Inc., granting approval for a generic rosu…